ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MDAI Spectral AI Inc

1.83
0.06 (3.39%)
27 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Spectral AI Inc NASDAQ:MDAI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.06 3.39% 1.83 1.46 2.28 1.83 1.77 1.80 81,103 05:00:02

Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call

01/11/2023 12:00pm

GlobeNewswire Inc.


Spectral AI (NASDAQ:MDAI)
Historical Stock Chart


From Jul 2023 to Jul 2024

Click Here for more Spectral AI Charts.

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2023 on Monday, November 13, 2023 after the close of the stock market. The Company will host a conference call on Tuesday, November 14, 2023 at 9:00 am Eastern Time to discuss the results.

Investors interested in participating in the live call can dial:

  • 833-630-1956 - U.S.
  • 412-317-1837 - International

A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events

About Spectral AI

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.

Contacts:Investors:Spectral AI Vince Capone   General Counsel ir@spectral-ai.com 

The Equity GroupDevin Sullivan, Managing Directordsullivan@equityny.comConor Rodriguez, Analystcrodriguez@equityny.com 

Media:Russo PartnersDavid SchullRusso Partners(858) 717-2310david.schull@russopartnersllc.com 

Guillermo Ruiz, M.D., Ph.D.Russo Partners(646) 218-4604guillermo.ruiz@russopartnersllc.com

1 Year Spectral AI Chart

1 Year Spectral AI Chart

1 Month Spectral AI Chart

1 Month Spectral AI Chart